Vaginal bleeding following the use of a single dose of 1.5mg levonorgestrel (LNG) for emergency contraception

Ao, Arowojolu; Okewole, IA

doi:10.4314/wajm.v23i3.28118

Cited by 7 publications

(6 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Thirty-five studies (3 UPA studies, 1 UPA and LNG study, 10 LNGs studies, 18 Yuzpe studies and 3 LNG and Yuzpe studies) examined AEs among populations of healthy women taking ECPs. Of these, 32 articles examined ECP use among healthy women with sample sizes ranging from 32 to 4129 women and reported no serious AEs [18,21,23–52]. Three studies reported AEs other than common ECP side effects (e.g., nausea, vomiting, changes to bleeding patterns) [14,20,22].…”

Section: Resultsmentioning

confidence: 99%

Safety data for levonorgestrel, ulipristal acetate and Yuzpe regimens for emergency contraception

2016

View full text Add to dashboard Cite

Evidence on safety of ECPs among women with characteristics or medical conditions listed within WHO and CDC family planning guidance is limited. However, both direct and indirect evidence for our study question did not suggest any special safety concerns for the use of ECPs among women with particular medical conditions or personal characteristics, such as pregnancy, lactation or frequent ECP use.

show abstract

Section: Resultsmentioning

confidence: 99%

Safety data for levonorgestrel, ulipristal acetate and Yuzpe regimens for emergency contraception

2016

View full text Add to dashboard Cite

show abstract

“…Женщины с корот-ким (<27 дней) или длительным (>29 дней) циклом отмеча-ют более постоянное его удлинение или укорочение соот-ветственно по сравнению с исходным уровнем [20][21][22].…”

Section: побочные эффекты тэкunclassified

“…Тошнота, изредка сопровождаемая рвотой, встречается менее чем у 20% женщин, придержи-вающихся вышеуказанного способа применения ЛНГ, и почти у 12% женщин, использующих улипристала ацетат [21]. Поскольку эти симптомы достаточно редки, то обыч-но не предусматривается прием противорвотного пре-парата перед использованием указанных гормональных средств.…”

Section: побочные эффекты тэкunclassified

See 1 more Smart Citation

Awareness about the effectiveness and safety of emergency contraception - a reserve in the prevention of unwanted pregnancy

Dikke

2016

Medicinskij sovet

View full text Add to dashboard Cite

The review tells about inadequate frequency of use (less than 1%) and low awareness (58--59%) among Russian women of emergency contraception, novel recommended medications and their effectiveness (52--100%) and safety according to recent clinical trials. Enhancing awareness of doctors and potential consumers of high efficacy and safety of emergency contraception would increase its use whenever necessary.

show abstract

“…[4][5][6] Side effects such as nausea, vomiting, dizziness, headache, and breast tenderness have been reported, however, they are not in comparison to each other, as to which side effects are reported most. 7 Stroke and cancer have been reported as adverse events for levonorgestrel. 8 In addition, the use of contraceptives has been related to pulmonary embolism and stroke, both of which have substantial mortality rates.…”

Section: Introductionmentioning

confidence: 99%

Effects of the use of contraceptives: a case of women in the Greater Accra and Ashanti regions of Ghana

Antwi,

Appiah,

Adu

2024

Int J Community Med Public Health

View full text Add to dashboard Cite

Background: Contraceptive use during a woman's reproductive years can help prevent unintended pregnancies, maternal deaths, and other non-reproductive problems. However, there is also a risk of running into various health challenges. The study aimed at finding out if women in the Greater Accra and Ashanti regions of Ghana encounter health issues during and after use of contraceptives was conducted. Methods: Questionnaires were administered to 600 women out of which 401 responses were carefully gleaned for analysis using SPSS version 25. The questionnaire probed side and adverse effects women encountered in their use of contraceptives as well as the types of contraceptives they preferred. Results: The study revealed that the use of contraceptives was widely prevalent, especially amongst women aged 21-30 years (61.8%). The preferred types of contraceptives were the oral-progestin only (42.9%) and combined oral contraceptives (31.4%). Spotting or bleeding between periods (menstrual-related) was the highest reported side effect (33.2%), followed by weight gain (metabolic-related), 21.7%. Pearson’s Chi squared test showed an association between the age of respondents and the choice of contraceptive type at p<0.01. Hypertension and deep vein thrombosis (DVT) were the highest reported adverse effect (10.2% and 9.2% respectively). Conclusions: It was concluded that contraceptive use (especially the oral type) may cause discomfort with the side effects reported in women of reproductive age and it may be a contributing factor to other health conditions in susceptible women.

show abstract

Vaginal bleeding following the use of a single dose of 1.5mg levonorgestrel (LNG) for emergency contraception

Cited by 7 publications

References 0 publications

Safety data for levonorgestrel, ulipristal acetate and Yuzpe regimens for emergency contraception

Safety data for levonorgestrel, ulipristal acetate and Yuzpe regimens for emergency contraception

Awareness about the effectiveness and safety of emergency contraception - a reserve in the prevention of unwanted pregnancy

Effects of the use of contraceptives: a case of women in the Greater Accra and Ashanti regions of Ghana

Contact Info

Product

Resources

About